Private limited company · Tubize · incorporated on 06/10/2000 · 1,4 ETP
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 371,1 k € | +83.6% | 202,1 k € | +13.8% | 177,5 k € | -24.0% | 233,6 k € | +32.9% | 175,8 k € | -43.6% | 311,9 k € | +117.0% | 143,7 k € | -36.5% | 226,2 k € | +71.3% | 132,0 k € | +410.8% | -42,5 k € | -132.6% | 130,2 k € | -8.2% | 141,8 k € | -20.4% | 178,2 k € | -26.9% | 243,9 k € | -47.9% | 468,0 k € | +42.3% | 328,8 k € | +119.4% | 149,9 k € | -22.2% | 192,7 k € | |
| EBITDA | 183,2 k € | +379.2% | 38,2 k € | -34.9% | 58,7 k € | +472.0% | 10,3 k € | -71.8% | 36,4 k € | -76.3% | 153,6 k € | +110.3% | 73,0 k € | -55.9% | 165,6 k € | +282.0% | 43,4 k € | +128.9% | -149,9 k € | -916.8% | 18,4 k € | -43.1% | 32,3 k € | -27.9% | 44,7 k € | -62.8% | 120,2 k € | -53.6% | 259,2 k € | +68.9% | 153,5 k € | +198.7% | 51,4 k € | -9.1% | 56,5 k € | |
| Operating profit | 170,9 k € | +355.9% | 37,5 k € | -19.9% | 46,8 k € | +3332.1% | -1,4 k € | -102.0% | 72,6 k € | +26.6% | 57,3 k € | +15.2% | 49,8 k € | -65.1% | 142,7 k € | +268.4% | 38,7 k € | +124.8% | -156,3 k € | -718.2% | 25,3 k € | -30.3% | 36,3 k € | +7.2% | 33,8 k € | -39.7% | 56,1 k € | -69.1% | 181,4 k € | +266.2% | 49,5 k € | +85.1% | 26,8 k € | -36.8% | 42,4 k € | |
| Profit/loss | 72,5 k € | +2215.8% | -3,4 k € | -112.7% | 26,9 k € | +176.7% | -35,1 k € | -197.0% | 36,2 k € | +109.8% | 17,2 k € | +2.8% | 16,8 k € | -71.2% | 58,3 k € | +363115.8% | -16,1 € | -101.2% | 1,3 k € | -80.4% | 6,8 k € | +168.1% | 2,5 k € | +122.3% | -11,4 k € | -164.0% | 17,8 k € | -75.6% | 72,7 k € | +513.1% | 11,9 k € | +46.8% | 8,1 k € | -46.3% | 15,0 k € | |
| Equity | 305,3 k € | +31.2% | 232,7 k € | -21.0% | 294,5 k € | +10.1% | 267,6 k € | -11.6% | 302,7 k € | +13.6% | 266,5 k € | +6.6% | 250,1 k € | +7.2% | 233,3 k € | +33.3% | 174,9 k € | -0.0% | 175,0 k € | +0.8% | 173,6 k € | +4.1% | 166,9 k € | +1.5% | 164,3 k € | -6.5% | 175,7 k € | +11.2% | 157,9 k € | +15.1% | 137,2 k € | +202.4% | 45,4 k € | +21.6% | 37,3 k € | |
| Total assets | 664,3 k € | +22.3% | 543,2 k € | -23.4% | 709,4 k € | -27.3% | 975,8 k € | -51.2% | 2,0 M € | +52.0% | 1,3 M € | -7.5% | 1,4 M € | -1.0% | 1,4 M € | +14.9% | 1,2 M € | -15.4% | 1,5 M € | +26.4% | 1,2 M € | +9.3% | 1,1 M € | -21.2% | 1,4 M € | +1.7% | 1,3 M € | -2.7% | 1,4 M € | +68.0% | 816,0 k € | +24.0% | 657,9 k € | +27.1% | 517,6 k € | |
| Cash | 240,7 k € | +231.0% | 72,7 k € | -45.8% | 134,3 k € | +121.4% | 60,6 k € | -81.6% | 329,9 k € | +341.7% | 74,7 k € | -55.0% | 166,1 k € | +606.7% | 23,5 k € | -15.8% | 27,9 k € | -93.1% | 403,9 k € | +240.8% | 118,5 k € | +107.6% | 57,1 k € | -40.0% | 95,1 k € | +236.5% | 28,3 k € | -71.5% | 99,1 k € | -23.9% | 130,3 k € | +1898.1% | 6,5 k € | +200.4% | 2,2 k € | |
| Debts | 359,0 k € | +15.7% | 310,4 k € | -25.2% | 414,8 k € | -41.4% | 708,2 k € | +1.9% | 694,7 k € | -32.1% | 1,0 M € | -12.6% | 1,2 M € | -2.6% | 1,2 M € | +11.9% | 1,1 M € | -17.0% | 1,3 M € | +30.2% | 994,2 k € | +10.3% | 901,3 k € | -24.4% | 1,2 M € | +2.9% | 1,2 M € | -4.2% | 1,2 M € | +78.1% | 678,8 k € | +11.0% | 611,7 k € | +32.3% | 462,3 k € | |
| Staff | 1,4 | 1,4 | 1,4 | 1,6 | 1,4 | 1,4 | 0,8 | 0,9 | 0,9 | 1,5 | 1,5 | 1,9 | 2,6 | 2,1 | 3,7 | 3,5 | 4,2 | 2,9 | ||||||||||||||||||
Private limited company profitable and well capitalised. Cash position rising (+231.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
ESCOS is a Private limited company incorporated in 2000. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Tubize. It employs on average 1,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette